Cloud-based platform enables use of AI on medical images

The Food and Drug Administration has approved Arterys' web-based imaging analytics platform, which marries cloud-based supercomputing and artificial intelligence, for clinical use. The FDA approval allows the Arterys product, called MICA, to supply clinical guidance to clinicians treating cardiac patients. The company is awaiting FDA clearance that would allow the platform to be used by oncology teams treating patients with lung and liver conditions. MICA is web-based and runs on a scalable distributed graphics processing architecture, enabling the product to apply various AI algorithms to image studies of specific cases. This addresses one of the major challenges of applying a variety of algorithms that use artificial intelligence to imaging studies--intelligently calling upon the right algorithm to provide guidance to clinicians while they are investigating a case or making treatment decisions.